MedTrace Logo

Hot Flash and Night Sweat Virtual Study

NCT06289907 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-03-04

No results posted yet for this study

Summary

The purpose of this research study is to evaluate the effectiveness of the study product on vasomotor symptoms (VMS) and overall menopause symptoms in healthy women, who are perimenopausal or postmenopausal, and aged 40 - 65.

Conditions

Interventions

DIETARY_SUPPLEMENT

Bonafide-HF3.0

Take 2 capsules once daily in the mornings with food

DIETARY_SUPPLEMENT

Placebo

Take 2 capsules once daily in the mornings with food

Sponsors & Collaborators

  • Lindus Health

    collaborator INDUSTRY

  • Bonafide Health

    lead INDUSTRY

Principal Investigators

  • Trisha VanDusseldorp, Ph.D. · Bonafide Health, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-09
Primary Completion
2024-05-30
Completion
2024-07-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06289907 on ClinicalTrials.gov